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ABSTRACT
During RNA-induced silencing complex (RISC)
assembly the guide (or antisense) strand has to
separate from its complementary passenger (or
sense) strand to generate the active RISC
complex. Although this process was found to be
facilitated through sense strand cleavage, there is
evidence for an alternate mechanism, in which the
strands are dissociated without prior cleavage. Here
we show that the potency of siRNA can be improved
by modulating the internal thermodynamic stability
profile with chemical modifications. Using a model
siRNA targeting the firefly luciferase gene with
subnanomolar IC50, we found that placement of
thermally destabilizing modifications, such as non-
canonical bases like 2,4-difluorotoluene or single
base pair mismatches in the central region of the
sense strand (9–12nt), significantly improve the
potency. For this particular siRNA, the strongest
correlation between the decrease in thermal stabil-
ity and the increase in potency was found at position
10. Controls with stabilized sugar-phosphate
backbone indicate that enzymatic cleavage of the
sense strand prior to strand dissociation is not
required for silencing activity. Similar potency-
enhancing effects were observed as this approach
was applied to other functional siRNAs targeting a
different site on the firefly luciferase transcript or
endogenously expressed PTEN.
INTRODUCTION
It is well established that long double-stranded RNA mol-
ecules, after being processed by the RNase III-like enzyme
Dicer into short interfering RNAs (siRNAs) of  21nt, as
well as synthetic siRNAs can be loaded into the
RNA-induced silencing complex (RISC) and mediate
sequence-speciﬁc gene silencing (1–3). Recently, a model
for the RISC-loading complex (RLC) was generated and a
mechanism proposed on how nascent siRNAs and
miRNAs are transferred from Dicer into AGO2 (4).
Activated RISC is composed of an Argonaute protein
(AGO2 in humans) and the unpaired guide strand,
which provides recognition of complementary mRNA
target sequences and serves as a ruler for highly site-
speciﬁc cleavage of the target RNA between positions 10
and 11 of the guide strand (5–9).
Several studies have investigated the fate of the passen-
ger strand addressing the question of when and how it is
removed from the guide strand (10–12). The data suggests
that the double-stranded siRNA rather than the unpaired
guide strand is loaded into RISC and, under normal con-
ditions, strand dissociation is facilitated by cleavage of the
passenger strand. This cleavage was found to occur pre-
cisely between positions 10 and 11 of the guide strand or
between 9 and 10nt, counting from the 50-end of the pas-
senger strand. In other words, the ﬁrst enzymatic cleavage
reaction of the RISC generates its activated form. Kinetic
analysis showed that RISC activity is rapidly generated if
the passenger strand can be cleaved, whereas
modiﬁcations that impair strand cleavage were also
found to impair silencing activity in cell culture.
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ism, in which the passenger strand dissociates from the
guide strand without prior cleavage. For instance,
miRNAs were found to efﬁciently be loaded into Ago2
RISC without cleavage of their natural passenger
strands, presumably because the multiple mismatches
typical of miRNA duplexes inhibit the cleavage-assisted
mechanism while accelerating the bypass mechanism
(11). In addition, several other reports indicate that
sense strands heavily modiﬁed at or around the putative
cleavage site can be well tolerated, suggesting that highly
potent effector complexes can be generated via an alter-
nate mechanism for passenger strand removal (13,14).
When the thermodynamic proﬁles of a relatively large
set of functional and non-functional siRNAs were
compared it was found that, besides terminal asymmetry
of the duplex, low internal duplex stability strongly
correlated with siRNA function (15).
The goal of the present study was to explore how modu-
lation of the thermodynamic proﬁle through incorpor-
ation of thermally destabilizing modiﬁcations, such as
universal bases and mismatches, in the passenger strand
affects siRNA potency. In a model siRNA directed
against luciferase some of the modiﬁcations showed an
up to 5-fold increase in potency. A comparison across
all nucleoside modiﬁcations studied showed that, particu-
larly at position 10 of the sense strand (complementary to
position 11 of the antisense strand), the increase in
potency correlated well with a decrease in thermal stability
exerted by the nucleobase modiﬁcations. To determine
whether this approach could be applied more broadly to
enhance siRNA activity, some representative modiﬁca-
tions were evaluated with additional siRNAs targeting
either a different site on the ﬁreﬂy luciferase transcript
or endogenously expressed PTEN (phosphatase and
tensin homolog).
MATERIALS AND METHODS
Synthesis of the 5-nitroindole ribonucleoside
phosphoramidite
The 5-nitroindole ribonucleoside phosphoramidite 7 was
prepared as outlined in Scheme 1 and as described below.
1-O-Methyl-2,3,5-tri-O-(2,4-dichlorobenzyl)-D-riboside
(2). 1-O-methyl-D-riboside 1 was synthesized as described
earlier (16). To a solution of 1 (13.43g, 81.83mmol), and
18-crown-6 (1.34g) in dry THF (100ml) was added
powered potassium hydroxide (69g, 1.23mol) and
stirred at room temperature for 40–60min. 2,4-
Dichlorobenzyl chloride (51ml, 368.2mmol) was added
drop-wise and the reaction mixture was stirred at the
same temperature overnight. The solids were ﬁltered off
and the ﬁltrate was concentrated into a crude residue,
which was applied to a column of silica gel and eluted
with hexanes-ethyl acetate (4:1) to give pure compound
2 (48g, 92%) as a white solid.
1H-NMR (CDCl3,
400MHz):   7.46–7.34 (m, 5H, ArH), 7.24–7.16 (m, 4H,
ArH), 4.99 (s, 1H, H-1), 4.71 [doublet of doublet (dd),
2H, Jgem=12.8Hz, OCH2Ar], 4.63–4.61 (m, 4H, 2
OCH2Ar), 4.38–4.36 (m, 1H), 4.19–4.16 (dd, 1H), 3.98
(d, 1H, J=4.4Hz), 3.75 (dd, 1H, J=3.6, 10.2Hz,
H-5a), 3.66 (dd, 1H, J=3.6, 10.4Hz, H-5b), 3.37
(s, 3H, OCH3).
1-Bromo-2,3,5-tri-O-(2,4-dichlorobenzyl)-D-ribose
(3). To a cold solution of 2 (3.22g, 5.02mmol) in dry
dichloromethane (50ml) cooled over an ice-bath was
added HOAc-HBr (5.3ml, 30%) and stirred at 0–25 C
for 3h. The reaction mixture was concentrated in vacuo
and the residue obtained was co-evaporated with toluene
(3 30ml). The crude syrupy product thus obtained could
be used for the next reaction without further puriﬁcation,
after drying under vacuum overnight.
1-(5-Nitroindole)-2,3,5-tri-O-(2,4-dichlorobenzyl)-
D-riboside (4). Sodium hydride (602mg, 15.06mmol,
60%) was added to a solution of 5-nitroindole (2.44g,
15.06mmol) in anhydrous CH3CN (30ml) over an ice
bath and stirred at ambient temperature for 3–4h under
argon atmosphere. The above obtained sugar donor 3 in
anhydrous CH3CN (10ml) was added to the reaction
mixture and stirred at the same temperature under argon
overnight. The solids were ﬁltered off and the ﬁltrate was
concentrated into a crude residue, which was applied to a
column of silica gel and eluted with hexanes-ethyl acetate
(3:1) to yield compound 4 (2.16g, 60%) as mixture of a
and b isomers (1:1).
1-[5-O-[bis(4-methoxyphenyl)phenylmethyl]-b-D-
ribofuranosyl]-5-nitro-1H-indole (5a) and 1-[5-O-
[bis(4-methoxyphenyl)phenylmethyl]-a-D-ribofuranosyl]-
5-nitro-1H-indole (5b). BCl3 in dichloromethane (23ml,
1.0M) was added to a cold solution of 4 (1.16g,
1.51mmol) in anhydrous dichloromethane (100ml) at
 78 C and stirred at the same temperature for 2h under
argon and at  40 C for 2h. The reaction mixture was
quenched with methanol–dichloromethane (1:1, 50ml)
and neutralized with ammonia–methanol solution. The
solids were ﬁltered off and the ﬁltrate was concentrated
to a crude residue, which was applied to a column of silica
gel and eluted with dichloromethane–methanol (10:1) to
give a pure compound (300mg, 68%) as a mixture of a
and b isomers (1:1). The mixture (840mg, 2.86mmol) thus
obtained was taken in anhydrous pyridine (3–4ml);
DMAP (90mg) and DMT-Cl (1.06g, 3.13mmol) were
added and stirred at ambient temperature under argon
overnight. The reaction mixture was concentrated
in vacuo and was subsequently puriﬁed by column chro-
matography (eluent: hexanes-ethyl acetate, 1:1) to afford
the desired b isomer 5a (550mg, 32.3%), the correspond-
ing a isomer 5b (190mg, 11.2%) and a mixture of both
compounds (360mg, 21.1%). The a isomer 5b with the
higher Rf-value eluted ﬁrst followed by the mixture and
single isomer 5a.
Compound 5a:
1H-NMR (CDCl3, 2D g-COSY and 2D
NOESY, 400MHz):   8.49 (d, 1H, J=1.6Hz), 8.35 (d,
1H), 8.03 (dd, 1H, J=2.0, 9.0Hz), 7.70–7.69 (m, 2H),
7.47–7.14 (m, 8H, ArH), 6.86–6.81 (m, 5H, ArH), 6.71
(d, 1H, J=3.6Hz), 6.41 (d, J=5.2Hz, H0-1), 4.73
(t, 1H, J=4.8Hz, H0-2), 4.46–4.42 (m, 3H, H0-3, H0-4,
Nucleic Acids Research, 2010,Vol.38, No. 20 7321H0-5), 3.79 (s, 6H, 2OCH3), 3.51 (dd, 1H, J=3.2,
10.4Hz, H0-5a), 3.26 (dd, 1H, J=3.2, 10.6Hz, H0-5b);
MWcalc for C34H32N2O8 (M + H)
+: 597.22, MWfound:
597.23.
Compound 5b:
1H-NMR (CDCl3, 2D g-COSY and 2D
NOESY, 400MHz):   8.55 (d, 1H, J=2.0Hz),
7.98 (dd, 1H, J=2.4, 9.2Hz), 7.60 (d, 1H, J=9.2Hz),
7.53 (d, 1H, J=3.2Hz), 7.44–7.42 (m, 2H), 7.34–7.24
(m, 7H, ArH), 6.84–6.81 (m, 4H, ArH),
6.68 (d, 1H, J=3.2Hz), 6.00 (d, 1H, J=5.2Hz, H0-1),
4.53 (t, 1H, J=7.6Hz), 4.46–4.44 (m, 1H), 4.23–4.20 (m,
1H), 3.80–3.76 (m, 7H, 2OCH3,H 0-5), 3.55 (dd, 1H,
H0-5a), 3.43 (dd, 1H, H0-5b); MWcalc for C34H32N2O8
(M+H)
+: 597.22, MWfound: 597.24.
1-[5-O-[bis(4-methoxyphenyl)phenylmethyl]-2-O-[(1,1-
dimethylethyl)dimethylsilyl]-b-D-ribofuranosyl]-5-nitro-
1H-indole (6a) and 1-[5-O-[bis(4-methoxyphenyl)phe-
nylmethyl]-3-O-[(1,1-dimethylethyl)dimethylsilyl]-b-D-
ribofuranosyl]-5-nitro-1H-indole (6b). TBDMSCl
(188mg, 1.20mmol) was added to a solution of 5a
(550mg, 0.92mmol), AgNO3 (188mg, 1.10mmol), and
pyridine (0.74ml, 9.2mmol) in dry THF (9.2ml) and
stirred at room temperature under an argon atmosphere
overnight. The solids were ﬁltered off and the ﬁltrate was
concentrated into a crude residue, which was applied to a
column of silica gel and eluted with hexanes-ethyl acetate
(4:1). Under the isocratic eluent condition, the faster
moving compound 6a with a slightly higher Rf-value
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Scheme 1. Synthesis of 5-nitroindole ribonucleoside phosphoramidite. (i) KOH, 2,4-dichlorobenzyl chloride, 18-crown-6/THF, room temperature,
overnight, 92%; (ii) HOAc-HBr, 0–25 C, 3h; (iii) NaH, 5-nitroindole/MeCN, ice bath to room temperature, 4h, Ar atm. 60%; (iv-a) BCl3/CH2Cl2,
 78 C for 2h,  40 C for 2h, a/b ratio 1:1; 68% and (iv-b). DMT-Cl, DMAP/Py, overnight, Ar. atm., combined yield: 64% (b isomer 5a (33%), a
isomer 5b (11%) and mixture 21%); (v) TBDMS-Cl, AgNO3, Py/THF, room temperature, overnight, combined yield: 75% (6a: 35%, 6b: 23% and
mixture: 17%); (vi) 2-cyanoethyl-N,N-diisopropylchlorophosphoramidite, DIEA/CH2Cl2, room temperature, overnight, 83%.
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then the pure fraction of compound 6b (Rf value: 0.35).
After analyzing column fractions individually by TLC the
pure fractions were pooled and evaporated in vacuo to
obtain compounds 6a (230mg, 35%), 6b (150mg, 23%),
and a mixture of compound 6a and b (110mg, 17%) in
total yield of 75%. After puriﬁcation, the purity of each
isomer was conﬁrmed by TLC and by NMR. The charac-
teristic H20 chemical shift of compound 6a appeared as a
doublet of doublet (dd) at 4.69ppm and H30 chemical shift
was indistinguishable from H40. The H30 peak of isomer
6b showed a downﬁeld shift to 4.51p.p.m. The identities
of the two isomers were further conﬁrmed by 2D proton
NMR (g-COSY and NOESY).
Compound 6a:
1H-NMR (CDCl3, 2D g-COSY, 2D
NOESY, 400MHz):   8.56 (d, 1H, J=2.4Hz), 7.88 (dd,
1H, J=2.4, 8.8Hz), 7.62 (d, 1H, J=9.2Hz), 7.54
(d, 1H, J=3.6Hz), 7.46–7.44 (m, 2H), 7.36–7.25
(m, 6H, ArH), 6.85–6.83 (d, 5H, ArH), 6.69
(d, 1H, J=3.6Hz), 5.94 (d, 1H, J=7.2Hz, H0 1),
4.69 (dd, 1H, H0 2), 4.31–4.29 (m, 2H, H0-3, H0-4),
3.80 (s, 6H, 2OCH3), 3.58 (dd, 1H, J=2.0, 10.6Hz,
H0-5a), 3.40 (dd, 1H, J=2.0, 10.4Hz, H0-5b),
2.85 (d, 1H, J=0.8Hz, 30-OH), 0.78 (s, 9H, t-Bu),
 0.016 (s, 3H, SiCH3),  0.43 (s, 3H, SiCH3); MWcalc
for C40H46N2O8Si (M+Na)
+: 733.29, MWfound: 733.30.
Compound 6b:
1H-NMR (CDCl3, 2D g-COSY, 2D
NOESY, 400MHz):   8.61 (d, 1H, J=2.4Hz), 8.05
(dd, 1H, J=2.0, 8.8Hz), 7.69–7.65 (m, 2H), 7.47–7.45
(m, 2H, ArH), 7.36–7.27 (m, 5H, ArH), 6.86–6.83
(m, 3H, ArH), 6.71 (d, 1H, J=3.2Hz), 5.99 (d, 1H,
J=4.8Hz, H0-1), 4.51 (t, 1H, J=4.8, 5.6Hz, H0-3),
4.40–4.36 (m, 1H, H0-2), 4.17–4.15 (m, 2H, H0-4, H0-5),
3.82 (s, 3H, OCH3), 3.81 (s, 3H, OCH3), 3.63 (dd, 1H,
J=2.4, 11.0Hz, H0-5a), 3.31 (dd, 1H, J=2.8, 11.0Hz,
H0-5b), 2.95 (d, 1H, J=6.0Hz, 20-OH), 0.91 (s, 9H, t-Bu),
0.05 (s, 3H, SiCH3), 0.00 (s, 3H, SiCH3); MWcalc for
C40H46N2O8Si (M+Na)
+: 733.29, MWfound: 733.28.
1-[5-O-[bis(4-methoxyphenyl)phenylmethyl]-3-O-
[[bis(1-methylethyl)amino](2-cyanoethoxy)phosphino]-
2-O-[(1,1-dimethylethyl)dimethylsilyl]-b-D-
ribofuranosyl]-5-nitro-1H-indole (7). 2-Cyanoethyl-N,N-
diisopropylchlorophosphoramidite (900mg, 3.80mmol)
was added to a solution of 6a (1.0g, 1.41mmol)
and diisopropylethylamine (1ml, 4 eqv.) in dry dichloro-
methane (10ml). The reaction mixture was stirred at
ambient temperature overnight under argon atmosphere.
The reaction mixture was concentrated to a crude residue,
which was applied to a column of silica gel packed in
hexanes containing 2% triethylamine and eluted with
10–25% ethyl acetate in hexanes to give a pure title
compound 7 (1.10g, 86%) as an amorphous solid.
31P-NMR (CDCl3, 400MHz):   149.53 (s), 146.56 (s).
RNA synthesis
RNA oligonucleotides (Supplementary Tables S1–8)
were synthesized at a scale of 1–2mmol on a ABI 394
DNA/RNA synthesizer using commercially available
50-O-DMT-30-O-(2-cyanoethyl-N,N-diisopropyl)
phosphoramidite monomers (ChemGenes Corporation) of
uridine, 4-N-acetylcytidine (C
Ac), 6-N-benzoyladenosine
(A
Bz) and 2-N-isobutyrylguanosine (G
iBu) with 20-O-
TBDMS protection and 50-O-DMT-thymidine-30-O-
(2-cyanoethyl-N,N-diisopropyl) phosphoramidite (dT)
following standard protocols for solid phase synthesis
and deprotection (17,18). 50-O-DMT-20-deoxy-2,4--
diﬂuorotoluene-ribofuranosyl-30-[(2-cyanoethyl)-(N,N-
diisopropyl)]-phosphoramidite, 50-O-DMT-20-deoxy-5-
nitroindole-ribofuranosyl-30-[(2-cyanoethyl)-(N,N-diiso-
propyl)]-phosphoramidite, 50-O-DMT-20-deoxyinosine-30-
[(2-cyanoethyl)-(N,N-diisopropyl)]-phosphoramidite,
50-O-DMT-inosine-20-O-TBDMS-30-[(2-cyanoethyl)-
(N,N-diisopropyl)]-phosphoramidite, 50-O-DMT-20-
deoxynebularine-30-[(2-cyanoethyl)-(N,N-diisopropyl)]-
phosphoramidite, 50-O-DMT-nebularine-20-O-TBDMS-
30-[(2-cyanoethyl)-(N,N-diisopropyl)]-phosphoramidite,
and 2-(O-DMT-oxymethyl)tetrahydrofurane-3-[(2-cyano-
ethyl)-(N,N-diisopropyl)]-phosphoramidite (dSpacer)
were obtained from Glen Research and used according
to the manufacturer’s protocols. 50-O-DMT-2-N-(di-
methylaminomethylidene)-20-deoxy-2-aminopurine ribo-
furanosyl-30-[(2-cyanoethyl)-(N,N-diisopropyl)]-phos-
phoramidite and 50-O-DMT-2-N-isobutyryl-2-
aminopurine ribofuranosyl-20-O-TBDMS-30-[(2-cyano-
ethyl)-(N,N-diisopropyl)]-phosphoramidite were obtained
from ChemGenes Corporation. We reported earlier on
the synthesis of 50-O-DMT-2,4-diﬂuorotoluene-20-O-
TBDMS-ribofuranosyl-30-[(2-cyanoethyl)-(N,N-
diisopropyl)]-phosphoramidite (19).
The crude oligonucleotides were analyzed by LC–MS
and puriﬁed by anion-exchange high-performance liquid
chromatography (IEX-HPLC) with TSK-Gel Super
Q-5PW support (TOSOH Bioscience, Inc.) using a linear
gradient of 22–42% buffer B in 130min. Solutions of
0.02M Na2HPO4 in 10% CH3CN, pH 8.5 and 0.02M
Na2HPO4/1M NaBr in 10% CH3CN pH 8.5 were used
as eluents A and B, respectively. To ensure high ﬁdelity of
the data, all single strands were HPLC puriﬁed to >85%
purity and puriﬁed oligonucleotides were desalted by size
exclusion chromatography on an Aekta Prime chromatog-
raphy system using an AP-2 glass column (Waters
Corporation) packed with Sephadex G25 (GE
Healthcare). The purity and identity of the oligonucleo-
tides was conﬁrmed by ion exchange chromatography and
LC–MS, respectively.
Duplex annealing
For duplex annealing, 1mM stock solutions in de-ionized
water were prepared for all single strands used in this
study. For the cell culture experiments, 0.05mM stock
solutions of siRNA in PBS were prepared by mixing
equimolar amounts of complementary sense and antisense
strands in PBS buffer and heating the solution to 95 C for
10min and allowing it to slowly cool to room temperature
to complete the annealing process. To ensure low variabil-
ity in duplex concentration, the optical densities of the
ﬁnal duplex solutions in PBS buffer were measured and
the duplex preparation was repeated if the optical density
Nucleic Acids Research, 2010,Vol.38, No. 20 7323was not within a 10% range of a reference sample (parent
duplex).
Thermal melting experiments
Experiments to determine the melting temperature (Tm)o f
siRNAs were performed with siRNA samples in sterile
0.9% physiological saline solution (154mM sodium
chloride in water for injection, pH 6.8). Prior to melting
experiments, siRNA duplexes were heated to 95 C for
 5min in a water bath, and then slowly cooled off in
the same water bath until they reached temperature
below 35 C. The sample concentration was adjusted to
 0.4 OD/ml by diluting the sample appropriately with
physiological saline solution. Samples were then ﬁltered
through a 0.45mm nylon ﬁlter (Whatman) into a 1cm
optical path length dry quartz micro-cuvette. The
cuvettes where capped with a Teﬂon cap and absorbance
values at 260nm were collected over the range 25–95 C
using a Beckman Coulter DU800 UV/VIS instrument with
Tm extension. Samples were allowed to equilibrate for
5min at the beginning temperature of each
heating-cooling cycle. Temperature was increased
linearly at a rate of  0.5 C/min while the absorbance
was monitored continuously. At the beginning of the
measurement baseline adjustment was carried out
against the 0.9% physiological saline solution. The Tm
values were calculated by the Beckman Coulter DU800
UV/VIS software. All experiments were run in duplicate
with less than ±0.1 C Tm value difference between runs.
Cell culture
Tissue culture medium, trypsin and Lipofectamine 2000
were purchased from Invitrogen. HeLa cells were
obtained from the American Type Tissue Collection.
The luciferase plasmids, renilla luciferase (pRL-CMV),
ﬁreﬂy luciferase (pGL3) and the Dual Glo Luciferase
Assay kit were purchased from Promega. HeLa SS6
cells, stably transfected with the luciferase plasmids,
renilla luciferase (pRL-CMV) and ﬁreﬂy luciferase
(pGL3), were grown at 37 C, 5% CO2 in Dulbecco’s
modiﬁed Eagles’s medium (GIBCO, Invitrogen) supple-
mented with 10% fetal bovine serum and 0.5mg/ml
zeocin and 0.5mg/ml puromycin (selective for cells trans-
fected with plasmids). The cells were maintained in expo-
nential growth phase.
Luciferase assay
The cells were plated in 96-well plates (0.1ml medium per
well) to reach  90% conﬂuence at transfection. The cells
were grown for 24h and the culture medium was changed
to OPTIMEM 1 (GIBCO, Invitrogen), 0.5ml per well.
Transfection of siRNAs was carried out with
Lipofectamine 2000 (Invitrogen) as described by the
manufacturer for adherent cell lines in the siRNA concen-
tration range of 0.002–8.0nM. The ﬁnal volume was
150ml per well. The cells were harvested 24h after trans-
fection, and lysed using passive lysis buffer (PLB), 100ml
per well, according to the instructions of the
Dual-Luciferase Reporter Assay System (Promega). The
luciferase activities of the samples were measured using a
Victor FL Luminometer (Perkin Elmer Corporation). The
volumes used were: 20ml of sample and 75ml of each
reagent (luciferase assay reagent II and Stop and Glo
Reagent). The inhibitory effects generated by siRNAs
were expressed as normalized ratios between the activities
of the reporter (ﬁreﬂy) luciferase gene and the control
(renilla) luciferase gene relative to untreated controls (no
siRNA, but with Lipofectamine 2000). Values represent
the mean of triplicates. The potency of the siRNAs was
determined by calculating the IC50-values from the corres-
ponding dose-response curves using XL-Fit software.
PTEN assay
The cells were plated in 96-well plates (0.1ml medium per
well) to reach  90% conﬂuence at transfection. The cells
were grown for 24h and the culture medium was changed
to OPTIMEM 1 (GIBCO, Invitrogen), 0.5ml per well.
Transfection of siRNAs was carried out with
Lipofectamine 2000 (Invitrogen) as described by the
manufacturer for adherent cell lines in the siRNA concen-
tration range of 0.002–8.0nM. Post-transfection, the cells
were lysed using Lysis Mixture (Panomics Quantigene
Assay Kit) and lysates were transferred to a 96-well
plate in the presence of PTEN speciﬁc probe sets
(Panomics Quantigene Assay Kit) and then incubated at
53 C overnight. On Day 2, the wells were washed and then
incubated with ampliﬁer (Panomics Quantigene Assay
Kit) at 46 C for 60min, followed by three washes and
then incubated with label probe for 60min at 46 C.
After the ﬁnal wash, chemoluminescent substrate
(Panomics Quantigene Assay Kit) was added to each
well and incubated for 30min at 46 C followed by quan-
tiﬁcation of the signal by a Victor FL Luminometer
(Perkin Elmer Corporation). Results were normalized to
housekeeping gene (GAPDH) signals for mRNA expres-
sion across samples. Values represent the mean of tripli-
cates. Additionally, a control, excluding cell lysate, was
used to determine any possible background signal from
reagents.
RESULTS
Effect of mismatches
The simplest way to locally destabilize siRNA duplexes is
to introduce base pair mismatches at the desired position.
Dependent on the mismatched base pair, its position in the
duplex, and the sequence, the thermal stability of a duplex,
as measured by the melting temperature in thermal de-
naturation experiments (Tm), can decrease over a wide
range, typically between 1 and 12K compared to the
fully complementary duplex (Supplementary Table S1).
Based on the parent unmodiﬁed RNA/RNA duplex of
siRNA-1 targeting ﬁreﬂy luciferase, all possible
mismatch combinations were walked through the entire
sequence of the sense strand, while the antisense strand
was left unchanged and hence fully complementary to
the target sequence on the mRNA.
Comparing the terminal mismatches, it appears that
destabilizing the 50-end of the sense strand (position 1)
led to a decrease in activity, while for incorporation of
7324 Nucleic Acids Research, 2010,Vol.38, No. 20base pair mismatches at the 30-end (position 19) no
changes in potency were observed (Figure 1). This is in
good agreement with the selection of guide and passenger
strand based on thermal asymmetry in the siRNA duplex
(15,20) and indicates that the model siRNA used in this
work was sufﬁciently biased for loading of the antisense
strand. Interestingly, some siRNAs with mismatches in the
central region, particularly at positions 9 and 10, exhibited
an increase in potency, as measured by a decrease in the
IC50-values and expressed as the ratio of IC50 (parent) to
IC50 (modiﬁed). In contrast, most mismatches at the other
internal positions (2–8 and 12–18) showed the opposite
trend.
Effect of base modiﬁcations in the central region of the
passenger strand
Non-polar nucleobase analogs, such as
2,4-diﬂuorotoluene (F), an isostere of thymine or
5-nitroindole, a purine analog, destabilize nucleic acid
duplexes predominantly because they have no or very
limited capability to form hydrogen bonds with the
nucleobase in the opposite strand (21–23). In one
example, crystal structure studies of duplexes containing
F indicate the presence of unconventional hydrogen bonds
in F:G pairs [F and H–N1(G)]. The corresponding
duplexes show a deviation from the canonical backbone
shape (24). When placed in the antisense strand of siRNA,
the effect of F residues on silencing activity was found to
be dependent on both, the position in the sequence and the
residue replaced with F:G pairs much less tolerated than
F:A (19,25).
Based on the ﬁndings with the mismatched base pairs,
we focused our efforts on the central region (positions 9–
12) of the sense strand and replaced single nucleotides with
various nucleobase modiﬁcations, both as ribo- as well as
deoxyribofuranosyl nucleotides (Figure 2). In addition to
the hydrophobic nucleobase isosteres 2,4-diﬂuorotoluene
(F) and 5-nitroindole (N), other nucleobase analogs, such
as inosine (I), nebularine (Neb) and 2-aminopurine (2AP),
which are capable of forming hydrogen bonds with
natural bases, were investigated.
Similar to the base pair mismatches, the degree of
thermal destabilization of the duplex varied between 1
and 12K compared to the unmodiﬁed parent
compound (Supplementary Table S2). The effect of the
modiﬁcations on the potency of the siRNA were found
to be dependent on the position as well as the type of
nucleobase modiﬁcation used (Figure 3A and B and
Supplementary Figure S1). The non-polar isostere F
exhibited a greater and more position-dependent effect
than any of the other nucleobase analogs. In contrast,
placement of N, which had previously been shown to be
the most ‘universal’ base (23), was found to be relatively
position-independent. Comparing the ribo- and
deoxyribofuranosyl analogs, there appears to be no
obvious correlation between the structure of the
pentose (ribose or deoxyribose) and the observed effects.
Correlation of potency enhancement with decrease in
thermal stability
The in vitro silencing data shows that, in general,
destabilizing modiﬁcations in the central region of the
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Figure 1. Effect of base pair mismatches across the sense strand sequence of siRNA-1 on potency relative to the parent duplex plotted as IC50
(parent)/IC50 (modiﬁed).
Nucleic Acids Research, 2010,Vol.38, No. 20 7325sense strand are not only well tolerated and but can even
be potency enhancing. The magnitude of the effect,
however, appears to be quite variable and seems to
depend on the modiﬁcation as well as its position.
Obviously, all nucleobase and mismatch modiﬁcations
introduced in this region affect the thermal stability of
the siRNA duplexes. However, dependent on the nature
of the non-canonical base pair formed between the
modiﬁed base in the sense strand and its counterpart in
the antisense strand, the degree of destabilization can be
expected to vary signiﬁcantly.
Focusing on the central positions 9–12, the thermal de-
naturation Tm of each duplex was determined
(Supplementary Table S2) and the correlation between
thermal stability and activity was investigated. Figure 4
shows the fold decrease in IC50 as a function of Tm
between the parent and the modiﬁed duplex. While at
positions 9, 11 and 12 the effect of the modiﬁcations on
the IC50 appears to be more or less independent of
the extend of thermal destabilization, a strong correl-
ation with a R
2 value of 0.76 was observed only at
position 10.
Head-to-head comparison of selected modiﬁcations
To conﬁrm the previous results and to determine the vari-
ability between separate experiments, a selected set of
modiﬁed siRNAs, including some of the most potent
ones, were subjected to a head-to-head comparison in
three independent transfection experiments. Figure 5
shows the dose–response curves of a representative experi-
ment and potency enhancement of the modiﬁed siRNAs
relative to the parent compound averaged over three in-
dependent experiments.
Although there is, as can be expected, some variability,
the rank order by IC50 across the independent experiments
is very similar (Supplementary Table S3) and the data
shows that the non-polar nucleobase isosteres
2,4-diﬂuorotoluene and 5-nitroindole, when incorporated
at position 10, led to a signiﬁcant increase in potency. The
effect was less pronounced with nucleobase analogs, which
are capable of forming hydrogen bonds with natural
bases, such as I and Neb. Particularly at position 10,
these modiﬁcations were found to have a smaller impact
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Figure 3. Effect of nucleobase modiﬁcations in positions 9–12 of the
sense strand of siRNA-1: (A) ribo- and deoxyribo versions of non-polar
nucleobase isosteres 2,4 diﬂuorotoluene (F, dF) and 5-nitroindole
(N, dN); (B) ribo- and deoxyribo versions of the nucleobase analogs
2-aminopurine (2AP, d2AP), inosine (I, dI) and nebularine (Neb,
dNeb); changes in potency relative to the parent siRNA are expressed
as IC50 (parent)/IC50 (modiﬁed).
H3C F
F
H
N N
O
O
(a) (b)
NH
N
O
N
N
N
N
N
N
N
N
N
N
NH2
(c) (d) (e)
Sense:               5' CUUACGCUGAGUACUUCGAdTdT
Antisense: 3' dTdTGAAUGCGACUCAUGAAGCU
Figure 2. Base modiﬁcations in the central region of the sense strand of siRNA-1: the positions of the parent duplex, which were replaced against the
nucleotide analogs, are shown in bold. (a) 2,4-diﬂuorotoluene (F and dF); (b) 5-nitroindole (N and dN); (c) inosine (I and dI); (d) nebularine
(Neb and dNeb); (e) 2-aminopurine (2AP and d2AP).
7326 Nucleic Acids Research, 2010,Vol.38, No. 20on thermal stability compared to 2,4-diﬂuorotoluene and
5-nitroindole (Supplementary Table S2).
Effect of backbone modiﬁcations
As shown above, the presence of mismatches or
nucleobase analogs adjacent to the putative cleavage site
on the sense strand between 9 and 10nt generally leads to
enhanced silencing activity although those modiﬁcations
can be expected to decrease the rate of enzymatic cleavage
or even prevent it. On the other hand, in a previously
reported study it was observed that the activity of a
luciferase siRNA was impaired after introducing
backbone modiﬁcations, such as 20-O-methyl-modiﬁcation
at position 9 and/or a phosphorothioate linkage between
nucleotides 9 and 10, into the sense strand (10). It targets
the same site on the luciferase transcript as siRNA-1 used
in the present work but contains 30-overhangs of different
sequence and chemistry. To rule out any involvement of
sense strand cleavage and to conﬁrm that the observed
potency enhancement is solely due to thermal destabiliza-
tion of the central part of the duplex, two additional ex-
periments were performed: (i) each of the 9–12nt in the
central region of the sense strand were replaced by an
abasic modiﬁcation, 2-hydroxymethyl-tetrahydrofurane-
3-ol; (ii) the putative cleavage site in the sense strand
was stabilized against enzymatic attack by incorporating
a2 0-O-methyl-modiﬁcation at position 9 and/or a
phosphorothioate linkage between nucleotides 9 and 10
in both, siRNA-1 as well as siRNA-2, identical to the
one described by Leuschner et al. (10).
Incorporation of the abasic modiﬁcation was found to
increase potency by  2–3-fold compared to the parent
unmodiﬁed duplex consistently across all central positions
(Figure 6A). Depending on the nucleotide replaced, a
decrease in thermal stability in the range of 9–15K was
observed (Supplementary Table S4). As expected, replace-
ment of G9 or G11 yielded a larger Tm decrease compared
to A10 and U12.
When the sugar-phosphate linkages at the putative
cleavage site between positions 9 and 10 in the sense
strands of siRNA-1 and siRNA-2 were modiﬁed with
20-O-methyl or a phosphorothioate linkage, no signiﬁcant
effect on potency could be detected (Figure 6B and
Supplementary Table S5). Even the combination of both
modiﬁcations did not result in a decrease in activity.
Furthermore, combined with the potency-enhancing F
residue in position 10, the activity of the backbone-
modiﬁed siRNAs was found to be still  3-fold higher
compared to the parent unmodiﬁed compound, albeit
slightly reduced compared to the analog lacking the
backbone modiﬁcations.
Additional siRNAs
To investigate whether manipulation of the thermal
duplex stability could be applied more generally to
enhance the potency of other functional siRNAs, a
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Nucleic Acids Research, 2010,Vol.38, No. 20 7327selected set of thermally destabilizing modiﬁcations was
introduced into the central region of the sense strands of
two additional siRNAs, one targeting ﬁreﬂy luciferase at a
different site on the transcript (siRNA-3) and one
(siRNA-4) targeting endogenously expressed PTEN (13).
The nucleobase isostere 2,4-diﬂuorotoluene (F), which
had been found to yield the most pronounced potency
enhancement, was walked through the central region of
the sense strand of siRNA-3, an example of a chemically
modiﬁed duplex containing 20-O-methyl modiﬁcations at
all pyrimidine positions in the sense strand as well as a few
20-O-methyl modiﬁcations in the antisense strand. Both
strands contain a phosphorothioate linkage in the over-
hangs (dTsdT). Similar to the results obtained with
siRNA-1, a signiﬁcant potency increase was observed
when F was placed at positions 10 and 11
(Supplementary Table S6 and Figure S2).
Again focusing our efforts on the central region of the
sense strand, all possible base pair mismatches at positions
9 and 10 and 2,4-diﬂuorotoluene (F) at positions 9–12
were evaluated for siRNA-4 targeting PTEN
(Supplementary Table S7). The study was carried out in
three independent experiments to evaluate the
reproducibility of the results (Figure 7). Replacement of
C10 against A and A9 against F yielded in average an
increase in potency of more than 8- and 5-fold, respective-
ly, which correlated with a substantial decrease in Tm of
 10–11K (Supplementary Table S7). While the other
mismatches generally exhibited a smaller decrease in Tm,
the effect of 2,4-diﬂuorotoluene was relatively
position-independent with a Tm-decrease in the range of
11–13K. More data from a larger set of analogs would be
required, however, to correlate potency enhancement with
the decrease in thermal stability at each of the positions.
DISCUSSION
During RISC assembly, one of the strands of the siRNA,
the passenger strand, has to be removed to enable the
formation of the active RISC complex. Previous studies
have shown that this can occur either by cleavage of the
passenger strand after loading of the entire duplex into
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Figure 6. (A) Effect of abasic modiﬁcations in positions 9–12 of the
sense strand of siRNA-1; (B) effect of 20-O-methyl and/or
phosphorothioate modiﬁcations between positions 9 and 10 of the
sense strands of siRNA-1 and siRNA-2; changes in potency relative
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B
A
Figure 5. Head-to-head comparison of a selected set of thermally
destabilizing modiﬁcations in the sense strand of siRNA-1: (A) repre-
sentative example of dose-dependent silencing of ﬁreﬂy luciferase as
percent untreated control; (B) potency enhancement of the modiﬁed
siRNAs relative to the parent duplex (average of three independent
transfection experiments).
7328 Nucleic Acids Research, 2010,Vol.38, No. 20RISC or by an alternative by-pass mechanism (10,11). The
goal of the present work was to investigate whether the
potency of siRNA can be further improved by modulating
the thermodynamic proﬁle with thermally destabilizing
modiﬁcations, such as base pair mismatches or nucleobase
analogs.
For a model siRNA targeting ﬁreﬂy luciferase, all
possible mismatch combinations were walked through
the entire duplex region of the sense strand of this
siRNA composed of 19 base pairs with 30-dTdT over-
hangs. In agreement with previous studies demonstrating
the signiﬁcance of thermodynamic asymmetry within
siRNA duplexes and the concomitant bias in RISC
loading (15,20), we found that mismatches at the 30-end
of the sense strand were well tolerated, while mismatches
at or near the 50-terminus signiﬁcantly decreased siRNA
potency. The fact that the former did not lead to further
improvement in potency suggests that the parent duplex
was sufﬁciently strand-biased for preferential loading of
the antisense strand. Most mismatches within the internal
sequence led to a more or less pronounced decrease in
activity. Surprisingly, however, mismatches in the central
region of the sense strand were not only well tolerated but,
in some cases, even led to a signiﬁcant increase in activity.
The largest potency enhancements were found at positions
9 and 10, which frame the putative cleavage site in the
sense strand.
To further investigate this phenomenon, we synthesized
a variety of siRNAs bearing nucleobase analogs in one of
the central positions 9–12 of the sense strand and
determined their ability to silence luciferase in comparison
to the unmodiﬁed parent duplex. The most pronounced
potency enhancement was observed by placing the hydro-
phobic thymidine isostere 2,4-diﬂuorotoluene in position
10. Other nucleobase modiﬁcations also showed some
potency-enhancing effect at various positions, albeit to a
lesser degree.
When a selected set of modiﬁed siRNAs, including
some of the most potent ones, was re-screened, the
non-polar nucleobase isosteres F and NI, incorporated
at position 10, consistently showed the most pronounced
increase in potency. The parent siRNA contains an adeno-
sine residue at this position 10 and the resulting
non-canonical F:U and N:U base pairs mimic the shape
of a T:U and a R(purine):U base pair, respectively.
Therefore, the local helix geometry can be expected to
vary signiﬁcantly. We have previously shown that,
whether or not single F or basepair mismatches in the
guide strand can be tolerated at or adjacent to the target
cleavage site (positions 10 and 11), critically depends on
the resulting non-canonical base pair formed (19).
Subsequent studies found that the observed activities
were inversely correlated with the backbone distortion re-
sulting from the modiﬁed base pair rather than being
affected by differences in thermal stability (24). If sense
strand cleavage by Ago2 slicer were a critical step in the
assembly of the RISC complex, one would expect to
observe a strong dependence of the siRNA activity on
the resulting non-canonical base pair with a clear trend
towards reduced potency. However, with the siRNA
used in this work, most base pair mismatches and
modiﬁed bases introduced in the central region of the
sense strand were not only well tolerated but even led to
enhanced potency.
If cleavage of the sense strand during RISC assembly is
not required, the observed increase in activity could either
be due to improved interaction of the modiﬁed siRNAs
with the RISC-loading complex or facilitated passenger
strand removal during RISC assembly due to a decrease
in thermal stability. In fact, a strong correlation between
Tm and potency enhancement was found at position 10,
at which we also observed the most pronounced increase
in activity. Although the correlation at the other positions
was less signiﬁcant, the most active siRNAs all exhibited a
substantial decrease in Tm compared to the parent duplex.
Notwithstanding the mismatch results, the observed
effects could potentially be explained by a simple
increase in strand bias and preferential loading of the anti-
sense strand due to the presence of non-natural
nucleobases in the sense strand. To rule out this possibil-
ity, we investigated the effect of chemically inactivated
sense and antisense strands by introducing several 20-O-
methoxyethyl modiﬁcations near the 50-end
(Supplementary Table S8 and Figure S3). The activity of
the siRNA was virtually unchanged with the modiﬁed
sense strand, while the same modiﬁcations in the antisense
strand completely abolished activity. This conﬁrms that (i)
placement of a few 20-O-methoxyethyl modiﬁcations at or
near the 50-end leads to strand inactivation and (ii) when
placed in the sense strand, they do not improve the activity
indicating that the parent siRNA is already sufﬁciently
strand biased towards preferential loading of the antisense
strand.
If the observed effect is due to thermal destabilization of
the central region of the duplex, the activity should also be
enhanced by other thermally destabilizing modiﬁcations
incapable of interacting with the bases of the opposite
strand. On the other hand, if passenger strand cleavage
is not required, the activity should not be affected by
backbone modiﬁcations, which stabilize against
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Sense strand modifications
Figure 7. Effect of base pair mismatches in positions 9,10 and 2,4-
diﬂuorotoluene (F) in positions 9–12 of the sense strand of siRNA-4
targeting PTEN; changes in potency relative to the parent siRNA are
expressed as IC50 (parent)/IC50 (modiﬁed).
Nucleic Acids Research, 2010,Vol.38, No. 20 7329nucleolytic cleavage. Hence, two additional sets of com-
pounds were made and tested—one with the central nu-
cleotides of the sense strand replaced by an abasic
modiﬁcation and one with modiﬁcations in the sugar-
phosphate backbone at position 9. For the latter experi-
ment, we included a siRNA, which contains different
overhangs but targets the same site on the ﬁreﬂy luciferase
transcript and which was reported previously to show
impaired activity if its passenger strand is modiﬁed at or
adjacent to the putative cleavage site (10). The abasic
modiﬁcation, which lacks the capability to form
hydrogen bonds with nucleotides in the opposite strand
as well as the stacking interactions with the neighboring
bases, caused a large thermal destabilization of the duplex.
All siRNAs modiﬁed with abasic residues not only ex-
hibited the expected decrease in Tm but also a 2–3-fold
increase in potency. In our hands and very consistent
across the two siRNAs, the backbone modiﬁcations,
when introduced at the putative cleavage site between pos-
itions 9 and 10 of the sense strand, did not signiﬁcantly
alter siRNA activity. Furthermore, siRNAs bearing F in
position 10 combined with backbone modiﬁcations, still
exhibited a 2–3-fold potency enhancement over to the un-
modiﬁed parent duplexes. Taken together, the results
indicate that, at least for the siRNAs used in this study,
sense strand cleavage during RISC assembly is not a
critical or rate limiting step and conﬁrm that thermal de-
stabilization rather than strand cleavage is responsible for
the observed potency enhancement.
Since the thermodynamic proﬁle depends on the
sequence of the siRNA duplex, it can be expected that
the effect of modiﬁcations, which modulate the thermal
stability, is similarly dependent on sequence and
position. Two additional siRNAs, one targeting ﬁreﬂy at
a different site on the transcript and one targeting en-
dogenously expressed PTEN, were used to determine
whether this approach could be applied more broadly to
enhance siRNA potency. A selected set of thermally
destabilizing modiﬁcations was introduced into the
central region of the sense strands of both siRNAs.
Although the degree and position-dependence of the
effects were found to vary slightly, the overall trend
towards improved potency was conﬁrmed. Thus, in agree-
ment with previous reports investigating the thermo-
dynamic proﬁle of functional siRNAs (15), our ﬁndings
suggest that the potency of a given siRNA duplex can be
further improved by modulating its internal stability
proﬁle.
CONCLUSION
We investigated the effect of non-canonical base pairs and
the concomitant local perturbation of the helical structure
and modulation of thermal stability on siRNA potency.
Our ﬁndings demonstrate that local destabilization of the
central region of the duplex through placement of base pair
mismatches or nucleobase modiﬁcations in thesense strand
of a siRNA directed against luciferase can lead to a signiﬁ-
cant improvement in silencing activity. A comparison
across all nucleoside modiﬁcations tested showed that the
potency increase correlated well with a decrease in thermal
stability. This trend was most pronounced at position 10 of
the passenger strand. Backbone modiﬁcations at the
putative sense strand cleavage site (positions 9 and 10),
which are known to stabilize against enzymatic cleavage
did not signiﬁcantly reduce the potency-enhancing effect.
When this approach was applied to other functional
siRNAs targeting either a different site on the same tran-
script or the transcript of a different, endogenously ex-
pressed gene (PTEN), similar potency-enhancing effects
were observed. In summary, our work indicates that
through selective manipulation of the thermodynamic
proﬁle, and speciﬁcally by decreasing thermal stability in
the central region of the duplex, the potency of a given
siRNA may be further enhanced.
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